Plain-language definitions grounded in the clinical and regulatory literature.
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Sleep Disorder Symptom
What it isA sudden loss of muscle tone triggered by strong emotion, usually laughter or surprise. The person stays conscious but cannot move for seconds to minutes.
Why it mattersCataplexy is a defining feature of narcolepsy type 1. It indicates loss of orexin-producing neurons and helps distinguish NT1 from other causes of excessive daytime sleepiness.
Think of it like thisImagine the muscle paralysis that normally only happens during REM sleep, the kind that stops you acting out dreams, getting triggered while you’re wide awake. That’s cataplexy.
Sudden bilateral loss of skeletal muscle tone with preserved consciousness, triggered most commonly by positive emotions (laughter), reflecting intrusion of REM-sleep atonia into wakefulness due to orexin/hypocretin neuron loss.
MechanismCataplexy results from abnormal activation of REM sleep motor circuits during wakefulness. Loss of orexin neurons removes the normal inhibitory restraint on the brainstem circuits that produce REM atonia. Emotional triggers, processed through the amygdala, activate these REM-motor circuits without the corresponding REM-sleep state.
Scientific ConsensusCataplexy is pathognomonic for narcolepsy type 1 and reflects orexin/hypocretin deficiency. It is triggered most commonly by laughter and positive emotions. Sodium oxybate, antidepressants, and pitolisant are effective treatments.
Active DebateWhether subtle cataplexy-like phenomena exist in narcolepsy type 2. The role of autoimmunity in initiating orexin neuron loss, and whether immunomodulatory therapy can prevent or reverse cataplexy if started early.
Emerging ResearchOrexin receptor agonists (TAK-994, danavorexton) in clinical trials may directly replace lost orexin signaling and abolish cataplexy. Improved diagnostic biomarkers including CSF orexin assays and HLA-DQB1*06:02 genotyping.
Key ResearchLin et al. (1999) and Chemelli et al. (1999) established the orexin-cataplexy link in canine and mouse models. Bassetti et al. (2019) provide the current canonical clinical review. Mahoney et al. (2019) detail the autoimmune hypothesis of orexin neuron loss.
— Current comprehensive clinical review of narcolepsy and cataplexy
— Mechanism of orexin neuron loss and autoimmune hypothesis
— REM sleep dysregulation underlying cataplexy and other narcolepsy symptoms
Sleep disorders, PTSD, and the invisible wounds of service can feel isolating. If you or someone you know is in crisis or experiencing thoughts of self-harm, help is available right now. The Veterans Crisis Line provides free, confidential support 24 hours a day, 7 days a week to veterans, service members, and their families.
If you are in crisis or experiencing thoughts of self-harm, call the Veterans Crisis Line at